ELTP Elite Pharmaceuticals, Inc.

$ELTP I think it is time they do a corporate update on what they are doing to get these shares moving up. what is going on with the drugs and update on uplisting or merger.... not wait till earnings.

$ELTP LETS ROLL Elite Pharmaceuticals is firing on all cylinders, and the future looks incredibly bright!For investors searching for a micro-cap company backed by explosive revenue and true profitability, ELTP stands out as an absolute gem. Here is why the momentum is strongly building:Record-Breaking Growth: Elite is crushing its financial goals, recently wrapping up fiscal year 2026 with a massive $149 million in revenue—a staggering +77% year-over-year surge!Real Earnings & Valuation: Unlike typical speculative stocks, Elite boasts a highly profitable operation with a positive EPS of $0.049 and a remarkably low, deeply undervalued trailing P/E ratio around 5.04. This gives the stock an immense runway for multiple expansion.Aggressive Product Rollouts: The company is rapidly scaling its "Elite Label" commercial generic line, successfully launching Methadone and Generic Requip XL just this year, with an exciting anticoagulant and generic OxyContin ER moving through the FDA pipeline.

$ELTP $GME $WEN Get Ready for a Ride...... The Facts are In..... Massive Revenue Scaling: Elite reported record fiscal year 2026 revenue of $149 million, showcasing an impressive 77% year-over-year surge. ADHD Market Dominance: The company commands a significant chunk of the central nervous system stimulant market, holding roughly 14% of generic Adderall volume and rapidly scaling its generic Vyvanse market share.Aggressive Pipeline Velocity: Recent commercial rollouts including generic Requip XL and Methadone Hydrochloride continue to diversify their cash flow away from a single therapeutic class. Strengthening Balance Sheet: Operating income reached $49 million in fiscal 2026, allowing the company to aggressively pay down long-term debt while building a cash runway exceeding $38 million. This Is Roaring Kitty. The Fun Starts NOW!!!!!!!

$ELTP want to buy again. Rode this up seems like two years ago and got out. Stock has been beaten up badly I see. For a profitable company this seems way overdone. What am I missing?

$ELTP 79 million warrants set to expire in April. A year w/o a buyout while actively searching for one. More than likely a reverse split to uplist. Real dilution concerns in the near future. Nasrat Hakim gets discretionary bonuses. They had a good swing with generic Vyvanse but had a big drop last earnings period because of lower margins. If margins remain low or lower, it's not a great sign. Oh, and a lot of investors got burned by that and/ or investing at the height of the last pump. You're better off waiting but it's your money.

$ELTP 🐂 Bull case The business is now profitable at scale. FY2026 revenue was $148.9M, up 77%, and operating income was $49.1M, up 151%. SSEC+1 Generic Vyvanse/lisdexamfetamine proved the commercial model. It was a major contributor to FY2026 results after its launch. SSEC Strong cash generation. At June 30, 2026, Elite had about $38.9M cash, versus $29.8M at March 31. Q1 operating cash flow was about $10.1M. SSEC There is room to add products. Elite has been expanding its generic portfolio rather than relying entirely on one drug. The company doesn't currently need the classic “biotech lottery ticket” outcome. It's already generating substantial revenue and profits from commercial products.

$ELTP tax loss harvesting season is upon us. ELTP will likely continue falling imo. Important stock trading lessons: 1) NEVER RIDE A STOCK DOWN. EVER. Especially an OTC stock. Once it drops 10%, or whatever level you decide, sell it, sell 20% per day or all at once, but start the selling process. YOU CAN ALWAYS BUY IT BACK LATER. I personally know people who had all their $$ in Enron stock in the early 2000s, and never sold any as it declined for a year all the way to zero. Dumb. 2) If a stock has been declining for awhile, then THE MARKET DOES NOT LIKE IT. It does not matter if you like it. BUY STOCKS THAT THE MARKET LIKES, OR WILL PROBABLY LIKE IN THE NEAR FUTURE. Then ride your winners, sell your losers. Simple. GLTALs!!

$ELTP This stock is heading down the toilet. Shrinking sales and margins. Only of value to management who can milk it dry. To the rest of the world it is just shank. Should be sub .20 soon.

$ELTP I think we hit .22 short term. Just reading the writing on the wall. I'm down on this stock substantially. I'm not saying don't buy or invest further. I'm saying don't do it just yet. Wait and see. Tons of warrants and a very lengthy M&A quest that has gone nowhere. Management dangles the uplisting carrot once again while paying out 5 mil bonuses that dull the incentive to walk the line. Many good businesses go down from poor management. Right now, it appears like they had a stroke of good luck. However, shoddy business sense trumps that in the end.

$ELTP Eh...Don't buy just yet. Fake bullish sign. They're dropping chump change at these levels. Wait until November.

$ELTP now down over 40% since some of you more than just disagreed with me on how horrible our CEO is. I’m guessing you still think he’s terrific and the cause of this stocks decline is fossil fuel or ozone related or pink fairies selling their 200,000,000 shares!!! I apologize, I was wrong, he’s the best!!! Like Jim Jones, pass the koolaid!!